UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
VRXAW holding history
Veraxa Biotech AG - Post de-SPAC in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRXAW overviewAll 13F holders of VRXAWFull Q2 2026 holdings
- Shares (Q2 2026)
- 1
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q2 2026